News

Prestige Scientific announces the successful completion of search #4197 Medical Director, Neurology MILFORD MA- April 2014-Prestige Scientific, an executive search firm that advises clients on recruiting impactful leaders, today announced its successful completion of Search Project #4197.  This completed search strengthens our client's clinical development function for multiple clinical programs in...

Prestige announces the successful completion of search #4163 Senior Director of Clinical Operations. MILFORD MA. -Jan.2014-Prestige Scientific, an executive search firm that advises pharmaceutical and biotech clients on recruiting impactful leaders, today announced its successful completion of Project #4163-Senior Director, Clinical Operations. This addition strengthens our...

Prestige announces the successful completion of search #4201 Global Senior Director of Quality MILFORD MA. - January 27, 2014-Prestige Scientific, an executive search firm that advises pharmaceutical and biotech clients on attracting impactful leaders, announced its successful completion of Project #4201 Global Senior Director of Quality....

July 22, 2013 Milford, MA Prestige Scientific announces the successful completion of search# 4161, Director of Clinical Trial Management for a small but ground breaking biopharmaceutical company.    The company is a privately held oncology-focused biopharmaceutical company whose passionate associates are dedicated to improving the lives of...

July 1, 2013 Milford, MA Prestige Scientific announces the successful completion of search# 4120, Director, Supply Chain for a mid-sized biopharmaceutical client.  This company engages in the development and commercialization of therapeutic products based on RNA interference (RNAi) in the United States.  Its RNAi development programs...

June 14, 2013 Milford, MA Prestige Scientific announces the successful completion of search# 4174 Director, Clinical Operations for a mid-sized biopharmaceutical client.  This company engages in the development and commercialization of therapeutic products based on RNA interference (RNAi) in the United States.  Its RNAi development programs...